A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL

Michaela Su-fern Seng, Zexi Guo, Kai Soon Ng, Shui Yen Soh, Francesca Wei Inng Lim, Liang Piu Koh, William YK. Hwang, Aloysius YL. Ho, Yeh Ching Linn, Esther Hian Li Chan, Michelle L.M. Poon, Lip Kun Tan, Mickey BC. Koh, Tun Kiat Ko, Jia Yu, King Pan Ng, Teck Guan Soh, Jason Yongsheng Chan, Joe Poh Sheng. Yeong, Rimas J. Orentas, Wing Leung

Open source

DOI: 10.1158/2643-3230.bcd-26-0115
Published: 2026-09-21
Container: Blood Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2643-3230.bcd-26-0115,
  title = {A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL},
  author = {Michaela Su-fern Seng and Zexi Guo and Kai Soon Ng and Shui Yen Soh and Francesca Wei Inng Lim and Liang Piu Koh and William YK. Hwang and Aloysius YL. Ho and Yeh Ching Linn and Esther Hian Li Chan and Michelle L.M. Poon and Lip Kun Tan and Mickey BC. Koh and Tun Kiat Ko and Jia Yu and King Pan Ng and Teck Guan Soh and Jason Yongsheng Chan and Joe Poh Sheng. Yeong and Rimas J. Orentas and Wing Leung},
  year = {2026},
  journal = {Blood Cancer Discovery},
  doi = {10.1158/2643-3230.bcd-26-0115},
  url = {https://doi.org/10.1158/2643-3230.bcd-26-0115}
}

RIS

TY  - JOUR
TI  - A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL
AU  - Michaela Su-fern Seng
AU  - Zexi Guo
AU  - Kai Soon Ng
AU  - Shui Yen Soh
AU  - Francesca Wei Inng Lim
AU  - Liang Piu Koh
AU  - William YK. Hwang
AU  - Aloysius YL. Ho
AU  - Yeh Ching Linn
AU  - Esther Hian Li Chan
AU  - Michelle L.M. Poon
AU  - Lip Kun Tan
AU  - Mickey BC. Koh
AU  - Tun Kiat Ko
AU  - Jia Yu
AU  - King Pan Ng
AU  - Teck Guan Soh
AU  - Jason Yongsheng Chan
AU  - Joe Poh Sheng. Yeong
AU  - Rimas J. Orentas
AU  - Wing Leung
PY  - 2026
JO  - Blood Cancer Discovery
DO  - 10.1158/2643-3230.bcd-26-0115
UR  - https://doi.org/10.1158/2643-3230.bcd-26-0115
ER  -

APA

Seng, M. S., Guo, Z., Ng, K. S., Soh, S. Y., Lim, F. W. I., Koh, L. P., Hwang, W. Y., Ho, A. Y., Linn, Y. C., Chan, E. H. L., Poon, M. L., Tan, L. K., Koh, M. B., Ko, T. K., Yu, J., Ng, K. P., Soh, T. G., Chan, J. Y., Yeong, J. P. S., Orentas, R. J., & Leung, W. (2026). A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-26-0115

Source records

crossref · retrieved 2026-09-27T00:42:46.151Z